Remove company genesis
article thumbnail

AI drug discovery company Genesis Therapeutics wins $200m in Series B round

Pharmaceutical Technology

The company’s generative and predictive AI-powered drug discovery platform is already being used by Eli Lilly.

98
article thumbnail

ERT to merge with clinical imaging firm Bioclinica

pharmaphorum

The companies said that the combination will strengthen their offering to pharmaceutical and biotech companies. The combined company will deliver data analytics, insights, business intelligence, virtual patient visits and hybrid technological solutions. .

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Innovation in immuno-oncology: Leading companies in T-cell culturing

Pharmaceutical Technology

GlobalData’s analysis also uncovers the companies at the forefront of each innovation area and assesses the potential reach and impact of their patenting activity across different applications and geographies.

article thumbnail

Leading innovators in transcription factors for genetically modified cells for the pharmaceutical industry

Pharmaceutical Technology

GlobalData’s analysis also uncovers the companies at the forefront of each innovation area and assesses the potential reach and impact of their patenting activity across different applications and geographies.

article thumbnail

2021 market access prospects for Spain

pharmaphorum

The health economic component of the revamped IPTs is informed by guidelines from the Grupo de Evaluación de Novedades, EStandarización e Investigación en Selección de Medicamentos (Group for the Evaluation of Innovations, Standardisation and Research in Drug Selection, GENESIS).

article thumbnail

Not every cough is COVID – MSD UK’s lung cancer campaign

pharmaphorum

As COVID cases surged last year, lung cancer referrals dropped in the UK, causing alarm to the UK Lung Cancer Coalition (UKLCC), an alliance of the UK’s leading lung cancer experts, senior NHS professionals, charities, and healthcare companies.

article thumbnail

Discover, Delve, and Develop: Expert Workshops at the 2023 ISPE Annual Meeting & Expo

ISPE

This workshop will provide participants with a comprehensive evaluation process and supporting assessment model for companies to evaluate their current status related to DT and identify areas of improvement and obstacles they may encounter on their way to mature their digital infrastructure.